Sponsored by ExThera: Hope for Critically Ill COVID-19 Patients: Pathogen Hemofiltration- Latest Data & Clinical Experience
Saves. They are the highlight of serving in the ICU. They are needed by critically ill COVID-19 patients and fatigued clinicians alike. Between timing of monoclonal antibody/antiviral medications and mechanical ventilation, therapy options have been limited for the COVID-19 critically ill. A new therapy is now available. Learn more about the impact of viremia, innovations in pathogen removal with a commercially available therapeutic, latest supporting data and literature, and ongoing clinical research looking to demonstrate clinical and economic benefit in a broader pathogen/septic shock all-comer population. Additionally, hear candid commentary from a Seraph 100 hands-on user concerning patient identification, timing of initiation, and best practices learned via experience in the ICU, followed by open Q&A.
This session was originally presented in September 2021 as part of the 2021 Sepsis Alliance Summit.
Nurses, Advanced Practice Providers, Physicians, Emergency Responders, Pharmacists, Medical Technologists, Respiratory Therapists, Physical/ Occupational Therapist, Social Workers, Mental Health Professionals, Students, IT Professionals, Sepsis Survivors, Advocates, and more!
Sepsis Alliance gratefully acknowledges the support provided for this session by ExThera Medical.
Lakhmir Chawla, MD
Adjunct Professor, Veterans Affairs Medical Center, San Diego, CA
Dr. Lakhmir (Mink) Chawla is Silver Creek Pharmaceutical’s Chief Medical Officer, and a Clinical Professor of Medicine at the UCSD Medical Center and Veterans Affairs Medical Center. Dr. Chawla was a Professor of Medicine at the George Washington University Medical Center in Washington, D.C. where he directed research efforts for the Division of Critical Care Medicine. He previously headed the Division of Intensive Care Medicine at the Washington DC Veterans Affairs Medical Center. With a focus on critical care and nephrology, Dr. Chawla has led and supported several grants and research projects centered on acute kidney injury, renal disease, extracorporeal therapies, shock, and sepsis.
Jaime Betancourt, MD
Associate Clinical Professor of Medicine, UCLA
Dr. Jaime Betancourt completed his medical training at the University of Texas Southwestern Medical Center, his Internal Medicine residency at the UCLA-VA Greater Los Angeles Healthcare System and his Pulmonary & Critical Care fellowship at Cedars-Sinai Medical Center in Los Angeles. He is board certified in Internal Medicine, Pulmonary Diseases and Critical Care Medicine. He has been in practice as a Pulmonary-Intensivist since 2011 and has also worked as a hospitalist and emergency room provider. As an Associate Clinical Professor of Medicine, he has extensive experience teaching medical students, residents and fellows at UCLA and its affiliated institutions in private, county and federal government facilities. His clinical focus is on providing pulmonary subspecialty outpatient & inpatient care as well as critical care in the medical intensive care unit for a diverse, medically underserved population.
No continuing education credits are offered for this session.
The information on or available through this site is intended for educational purposes only. Sepsis Alliance does not represent or guarantee that information on or available through this site is applicable to any specific patient’s care or treatment. The educational content on or available through this site does not constitute medical advice from a physician and is not to be used as a substitute for treatment or advice from a practicing physician or other healthcare provider. Sepsis Alliance recommends users consult their physician or healthcare provider regarding any questions about whether the information on or available through this site might apply to their individual treatment or care.